South America Peripheral Vascular Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis

List of Tables

The SAM peripheral vascular devices market is expected to grow from US$ 894.09 million in 2021 to US$ 1,228.74 million by 2028; it is estimated to register a CAGR of 4.6% from 2021 to 2028.

The three most common CVDs across the region are coronary heart disease, cerebrovascular disease, and peripheral artery disease. Although cardiovascular disease prevention and control has gained traction in recent decades, efforts have primarily focused on coronary heart disease and cerebrovascular disease, the world's leading causes of mortality. Despite receiving less attention, peripheral artery disease has emerged as a significant contributor to the worldwide deaths and disabilities, with an increasing burden in low-income and middle-income countries (LMICs). A blockage in the blood vessels causes peripheral arterial disease (PAD) or peripheral vascular disease (PVD), which reduces blood flow to the limbs, most commonly the legs. An arterial embolism occurs when a mass of tissue or a foreign substance moves through the vascular tree and lodges in a distant artery, blocking blood flow. Ischemia, organ failure, and possible infarction result from this blockage. Medical and surgical emergencies, such as stroke, acute limb ischemia, mesenteric ischemia, and renal failure, are symptoms of this complex condition. Due to pre-existing factors, such as age, hypercoagulability, cardiac abnormalities, and atherosclerotic disease, surgical and intensive care patients are at a higher risk for arterial embolization. These factors are supporting the peripheral vascular devices market substantially across the region.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM peripheral vascular devices market at a notable CAGR during the forecast period.

SAM Peripheral Vascular Devices Market Revenue and Forecast to 2028 (US$ Million)

SAM Peripheral Vascular Devices Market Segmentation

The SAM peripheral vascular devices market is segmented into product, end user, and country. Based on product, the SAM peripheral vascular devices market is segmented into peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, PTA guidewires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, and embolization guidewires. Further, the peripheral vascular stents segment dominated the market in 2021. Based on end user, the SAM peripheral vascular devices market is segmented into hospitals & clinics, ambulatory care centers, specialty clinics, and others. Further, the hospitals & clinics segment dominated the market in 2021. Based on country, the SAM peripheral vascular devices market is segmented into Brazil, Argentina, and the Rest of SAM. Further, Brazil dominated the market in 2021.

Abbott, B. Braun Melsungen AG, BD, Boston Scientific Corporation, Cardinal Health Inc, Cook Medical LLC, Edwards Lifesciences Corporation, Medtronic, Teleflex Incorporated, and Terumo Corporation are among the leading companies operating in the SAM peripheral vascular devices market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM peripheral vascular devices market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the SAM peripheral vascular devices market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the peripheral vascular devices market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Product Code: BMIRE00025630

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 SAM Peripheral Vascular Devices Market - By Product
- 1.3.2 SAM Peripheral Vascular Devices Market - By End-User
- 1.3.3 SAM Peripheral Vascular Devices Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. SAM Peripheral Vascular Devices Market - Market Landscape

4.1 Overview
4.2 SAM PEST Analysis
4.3 Experts Opinion

5. SAM Peripheral Vascular Devices Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Incidences of Atherosclerosis, Smoking, Alcoholism, and Obesity
- 5.1.2 Increasing Prevalence of Peripheral Artery Disease and Arterial Embolism
5.2 Market Restraints
- 5.2.1 High Costs and Complications Associated with Embolization Procedures
5.3 Market Opportunities
- 5.3.1 Growing Geriatric Population
5.4 Future Trends
- 5.4.1 Technological Advancements in Embolization Products and Procedures
5.5 Impact Analysis

6. Peripheral Vascular Devices Market - SAM Analysis

6.1 SAM Peripheral Vascular Devices Market Revenue Forecast and Analysis

7. SAM Peripheral Vascular Devices Market Analysis - By Product

7.1 Overview
7.2 SAM Peripheral Vascular Devices Market Share by Product - 2021 & 2028 (%)
7.3 Peripheral Vascular Stents
- 7.3.1 Overview
- 7.3.2 Peripheral Vascular Stents: Peripheral Vascular Devices Market Revenue and Forecast to 2028 (US$ Million)
7.4 Peripheral Transluminal Angioplasty Balloon Catheters
- 7.4.1 Overview
- 7.4.2 Peripheral Transluminal Angioplasty Balloon Catheters: Peripheral Vascular Devices Market Revenue and Forecast to 2028 (US$ Million)
7.5 PTA Guidewires
- 7.5.1 Overview
- 7.5.2 PTA Guidewires: Peripheral Vascular Devices Market Revenue and Forecast to 2028 (US$ Million)
7.6 Atherectomy Devices
- 7.6.1 Overview
- 7.6.2 Atherectomy Devices: Peripheral Vascular Devices Market Revenue and Forecast to 2028 (US$ Million)
7.7 Chronic Total Occlusion Devices
- 7.7.1 Overview
- 7.7.2 Chronic Total Occlusion Devices: Peripheral Vascular Devices Market Revenue and Forecast to 2028 (US$ Million)
7.8 Aortic Stents
- 7.8.1 Overview
- 7.8.2 Aortic Stents: Peripheral Vascular Devices Market Revenue and Forecast to 2028 (US$ Million)
7.9 Synthetic Surgical Grafts
- 7.9.1 Overview
- 7.9.2 Synthetic Surgical Grafts: Peripheral Vascular Devices Market Revenue and Forecast to 2028 (US$ Million)
7.10 Embolization Guidewires
- 7.10.1 Overview
- 7.10.2 Embolization Guidewires: Peripheral Vascular Devices Market Revenue and Forecast to 2028 (US$ Million)

8. SAM Peripheral Vascular Devices Market Analysis - By End-User

8.1 Overview
8.2 SAM Peripheral Vascular Devices Market Share by End-User - 2021 & 2028 (%)
8.3 Hospitals & Clinics
- 8.3.1 Overview
- 8.3.2 Hospitals & Clinics: Peripheral Vascular Devices Market Revenue and Forecast to 2028 (US$ Million)
8.4 Ambulatory Care Centers
- 8.4.1 Overview
- 8.4.2 Ambulatory Care Centers: Peripheral Vascular Devices Market Revenue and Forecast to 2028 (US$ Million)
8.5 Specialty Clinics
- 8.5.1 Overview
- 8.5.2 Specialty Clinics: Peripheral Vascular Devices Market Revenue and Forecast to 2028 (US$ Million)
8.6 Others
- 8.6.1 Others: Peripheral Vascular Devices Market Revenue and Forecast to 2028 (US$ Million)

9. SAM Peripheral Vascular Devices Market - Country Analysis

9.1 Overview
- 9.1.1 SAM Peripheral Vascular Devices Market Revenue and Forecasts to 2028, By Country (%)
  - 9.1.1.1 Argentina Peripheral Vascular Devices Market Revenue and Forecasts to 2028 (US$ Million)
    - 9.1.1.1.1 Overview
    - 9.1.1.1.2 Argentina Peripheral Vascular Devices Market Revenue and Forecasts to 2028 (US$ Million)
    - 9.1.1.1.3 Argentina: Peripheral Vascular Devices Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 9.1.1.1.4 Argentina: Peripheral Vascular Devices Market Revenue and Forecasts To 2028, By End User (US$ Million)
  - 9.1.1.2 Brazil: Peripheral Vascular Devices Market Revenue and Forecasts to 2028 (US$ Million)
    - 9.1.1.2.1 Overview
    - 9.1.1.2.2 Brazil: Peripheral Vascular Devices Market Revenue and Forecasts to 2028 (US$ Million)
    - 9.1.1.2.3 Brazil: Peripheral Vascular Devices Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 9.1.1.2.4 Brazil: Peripheral Vascular Devices Market Revenue and Forecasts To 2028, By End User (US$ Million)
  - 9.1.1.3 Rest of SAM: Peripheral Vascular Devices Market- Revenue and Forecast to 2028 (USD Mn)
    - 9.1.1.3.1 Overview
    - 9.1.1.3.2 Rest of SAM: Peripheral Vascular Devices Market- Revenue and Forecast to 2028 (US$ Million)
    - 9.1.1.3.3 Rest of SAM: Peripheral Vascular Devices Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 9.1.1.3.4 Rest of SAM: Peripheral Vascular Devices Market Revenue and Forecasts To 2028, By End User (US$ Million)

10. Industry Landscape

10.1 Overview
10.2 Organic Developments
- 10.2.1 Overview
10.3 Inorganic Developments
- 10.3.1 Overview

11. Company Profiles

11.1 Abbott
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Edwards Lifesciences Corporation
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Medtronic
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Teleflex Incorporated
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Boston Scientific Corporation
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 BD
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Cook Medical LLC
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Terumo Corporation
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 B. Braun Melsungen AG
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 Cardinal Health Inc
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Glossary of Terms